Piper Sandler Downgrades Trupanion to Neutral, Lowers Price Target to $32
Piper Sandler analyst David Westenberg downgrades Trupanion (NASDAQ:TRUP) from Overweight to Neutral and lowers the price target from $45 to $32.
Read original at benzingaStocks · News reference
Trupanion Announces $100M Buyback Plan
Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced its Board has authorized a share repurchase program, pursuant to which the Company may repurchase up to an
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 5, 2026, 8:39 PM
- Checked
- Aug 5, 2026, 8:39 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Stifel Maintains Hold on Trupanion, Raises Price Target to $29
Stifel analyst Jonathan Block maintains Trupanion (NASDAQ:TRUP) with a Hold and raises the price target from $28 to $29.
Read original at benzingaTrupanion Sees Q3 Sales $399.000M-$405.000M vs $398.218M Est
Trupanion (NASDAQ:TRUP) sees Q3 sales of $399.000 million-$405.000 million vs $398.218 million analyst estimate.
Read original at benzingaTrupanion Raises FY2026 Sales Guidance from $1.556B-$1.581B to $1.584B-$1.601B vs $1.579B Est
Trupanion (NASDAQ:TRUP) raises FY2026 sales outlook from $1.556 billion-$1.581 billion to $1.584 billion-$1.601 billion vs $1.579 billion estimate.
Read original at benzinga